Clinical Trials
6 trialsNCT05838599 2026-05-01
Combining Topical Imiquimod With Local Radiotherapy for Treatment of Mycosis Fungoides
Northwestern University
Phase EARLY_PHASE1 Recruiting
NCT03276832 2026-03-19
Imiquimod and Pembrolizumab in Treating Patients With Stage IIIB-IV Melanoma
Mayo Clinic
Phase EARLY_PHASE1 Completed
NCT03196180 2025-04-08
Topical Fluorouracil and Imiquimod in Treating Patients With High-Grade Cervical Intraepithelial Neoplasia
National Cancer Institute (NCI)
Phase EARLY_PHASE1 Completed
NCT04883645 2025-01-28
Neoadjuvant Imiquimod Immunotherapy for Oral Cancer
Medical University of South Carolina
Phase EARLY_PHASE1 Completed
NCT01678352 2020-02-24
Imiquimod and Tumor Lysate Vaccine Immunotherapy in Adults With High Risk or Recurrent Grade II Gliomas
University of Pittsburgh
Phase EARLY_PHASE1 Completed
NCT03116659 2019-08-13
CTCL Directed Therapy
James J. Peters Veterans Affairs Medical Center
Phase EARLY_PHASE1 Unknown